Xiao Ying Meng
Director/Board Member at BMC MEDICAL CO., LTD.
Profile
Xiao Ying Meng is currently the Director at BMC Medical Co. Ltd.
since 2019 and the Non-Executive Director at TYK Medicines, Inc. since 2021.
Previously, she worked as a Member-Supervisory Board at Chengdu Bright Eye Hospital Co., Ltd.
from 2018 to 2022.
Dr. Meng holds a doctorate degree from The Pennsylvania State University, an undergraduate degree from Nanjing University, and a graduate degree from Nanjing University.
Xiao Ying Meng active positions
| Companies | Position | Start |
|---|---|---|
| BMC MEDICAL CO., LTD. | Director/Board Member | 2019-11-30 |
TYK Medicines, Inc.
 TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Director/Board Member | 2020-12-31 |
Former positions of Xiao Ying Meng
| Companies | Position | End |
|---|---|---|
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Director/Board Member | 2022-10-09 |
Training of Xiao Ying Meng
| The Pennsylvania State University | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BMC MEDICAL CO., LTD. | Health Technology |
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Health Services |
| Private companies | 1 |
|---|---|
TYK Medicines, Inc.
TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Health Technology |
- Stock Market
- Insiders
- Xiao Ying Meng
